Bringing News as it Unfolds
The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending nivolumab-relatlimab (Opdualag) for people aged 12 or older with untreated advanced melanoma, making nearly 1300 patients eligible for the treatment.1
The combination of two monoclonal antibodies is given …
Spread the love As of 2022, the global vitamin supplement industry was valued at $48.51 billion. It is projected to rise moderately by about 7.3% in 2030. The market in the U.S. alone was valued at $13.3 billion as of 2021. The growth is attributed to the increasing adoption of dietary supplements in daily nutrition […]
Spread the love This story is part of CBC Health’s Second Opinion, a weekly analysis of health and medical science news emailed to subscribers on Saturday mornings. If you haven’t subscribed yet, you can do that by clicking here. If you consider yourself at a higher risk of serious illness from COVID-19 — because of your age, […]
Spread the loveWith the rise in liver diseases worldwide, it is crucial for individuals to understand the importance of regular check-ups and monitoring of their liver health. Early detection of liver issues can be life-saving, as liver diseases often show few to no symptoms until they are advanced and may result in irreversible damage. Through […]
